seco international 2015 course #137 (hsv) · herpetic simplex virus • hsv is a double-stranded...
TRANSCRIPT
1
All About Herpes Simplex SECO International 2015
Course #137 Daryl F. Mann, O.D.
President SouthEast Eye Specialists, PLLC
Chattanooga & Knoxville, TN
HERPES SIMPLEX VIRUS (HSV)
• 500,000 people in US with HSV-related ocular disease1
• 20,000 new episodes & 28,000 reactivations yearly1
• Leading cause of corneal blindness in US2; 2nd in World
1Wang JC. Keratitis, Herpes Simplex. Emedicine. Accessed online from: http://emedicine.medscape.com/article /1194268-overview.
2Liesegang,TJ, Melton LJ, 3rd, Daly PJ, Ilstrup DM. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950-1982. Arch Ophthalmol 1989;107:1155-9.
Herpetic Simplex Virus
• HSV is a double-stranded DNA virus that causes disease after direct contact with skin or mucosal membranes by virus-laden secretions from an infected host.1
• HSV Type 1 • HSV Type 2
1Welder JD, Kitzmann AS, Wagonger MD. Herpes Simplex Keratitis. Accessed online from http://webeye.ophth.uiowa.edu.
Herpetic Simplex Virus
• HSV Type 1 – Above the waist – Bimodal onset – Nearly 100% of adults > age 60 harbor HSV @
autopsy1 • HSV Type 2
– Below the waist – STD
1AAO Basic and Clinical Science Course, External Disease and Cornea 2010-2011
Primary HSV Infection
• More common in childhood • Non-ocular
– Flu-like symptoms – Self-limited
• Ocular – Follicular conjunctivitis OU – Periocular HSV blisters on
lids – Self-limited
Recurrent Ocular HSV Infection
• Once in tissue, virus spreads from site of the initial infection to the neuronal cell bodies
• Can lie dormant for years • Most ocular HSV infections are
secondary • Trigger Mechanism
– Stress, illness, menses, immunosuppression, sun exposure, fever, trauma.
• Past ocular history most significant risk factor
2
Recurrent Ocular HSV Infection
• Blepharitis • Conjunctivitis • Scleritis • Anterior Uveitis • Necrotizing Retinitis • Choroiditis • Optic Neuritis
HSV-Keratitis: Clinical Presentation
• Epithelial Dendrite • Geographical dendrite • Stromal
– Non-necrotizing & necrotizing
• Endothelial (disciform) • Metaherpetic • Most cases are (> 90%) unilateral1
1Welder JD, Kitzmann AS, Wagonger MD. Herpes Simplex Keratitis. Accessed online from http://webeye.ophth.uiowa.edu.
Recurrent HSV-K Infection
• Epithelial keratitis – 75% have epithelial
involvement – Invariably involves
active viral proliferation
Limbal HSV-K
Limbal HSV Recurrent HSV-K Infection
• Stromal keratitis – 25% have stromal
involvement – Non-necrotizing – Necrotizing – Disciform (endothelial)
3
Disciform HSV-K Non-necrotizing Stromal HSV-K
Necrotizing Stromal HSV-K Geographic HSK
Metaherpetic/Neurotrophic HSV-K HSV-K: Clinical Diagnosis
• Tests – Tzanck (Giemsa) – Viral culture – Viral antigen assay – PCR
• Clinical Diagnosis – History & symptoms – Clinical appearance
4
Epithelial HSV-K Epithelial HSV-K
HSV-K: Clinical Diagnosis
• Vital stains – Rose Bengal
Rose Bengal
HSK: Clinical Diagnosis
• Vital stains – Rose Bengal – Fluorescein
Pseudo-dendrites
5
HSK: Clinical Diagnosis
• History & Symptoms • Clinical appearance • Vital stains
– Rose Bengal – Fluorescein
• Corneal hypesthesia – Cochet-Bonnet
aethesiometry
HSK: Clinical Diagnosis
• History & Symptoms • Clinical appearance • Vital stains
– Rose Bengal – Fluorescein
• Corneal hypoesthesia • Level of Suspicion • Response to treatment
& non-treatment
Management HSV-K
• Topical Antivirals – Zirgan (ganciclovir ophthalmic gel) 0.15% – Viroptic (trifluridine ophthalmic)
• Oral Antivirals – Acyclovir (Zovirax) – Valacyclovir (Valtrex) – Famciclovir (Famvir)
• Topical Corticosteroids
Guiding Principle for treatment of HSV-K1
• Prior to onset of immune-mediated disease, control and elimination of epithelial manifestations is the highest priority.
• However, once immune-mediated disease has been established, management of stromal or endothelial manifestations, with their potential for irreversible visual impairment, has higher priority than control of epithelial disease.
29
Zirgan® (ganciclovir ophthalmic gel) 0.15%
• FDA approved ZIRGAN for sale on Sept 15, 2009...Bausch & Lomb purchased the U.S. rights from Sirion
• The recommended dosing regimen for Zirgan is 1 drop in the affected eye 5 times per day (approximately every 3 hours while awake) until the corneal ulcer heals, and then 1 drop 3 times per day for 7 days.
Please see full Zirgan® Webinar Deck PH3234 07/10 © 2010 Bausch & Lomb Incorporated Zirgan® is a trademark of Laboratories Théa Corporation licensed by Bausch & Lomb Incorporated All other product/brand names are trademarks of their respective owners.
Oral Antivirals for HSV
• Acyclovir (Zovirax) – 200 mg & 400 mg – 400 mg 5 X day x 14-21 days
• Valacyclovir (Valtrex) – Pro drug with 3-4x conc; 500 mg & 1 gm – 500 gms 3 X per day x 14-21 days
• Famciclovir (Famvir) – 125 mg, 250 mg & 500 mg – 1.0 gms per day
6
HEDS I Outcomes
• Steroids are helpful in tx of stromal disease • No apparent benefit of adding acyclovir to
treatment regimen of steroid and anti-viral for stromal disease
• Possible benefit of adding acyclovir in tx of HSV iritis to tx regimen of Viroptic & steroid
HEDS II Outcomes
• No benefit of adding oral acyclovir to tx regimen of topical trifluridine in the prevention of HSV stromal keratitis
• Oral acyclovir (400 mg bid) reduced recurrent rate 41% of any recurrence and 50% of stromal recurrence
• External factors???
Treatment Plan HSV-K
• Epithelial – Zirgan: 5 gtts/day an taper –OR- – Viroptic: 9 gtts/day and taper
– Acyclovir: 2 gms/day and taper? -OR- – Valtrex: 1.5 gms/day and taper?
Treatment Plan HSV-K
• Epithelial – Zirgan: 5 gtts/day and taper – Viroptic: 9 gtts/day and taper – Acyclovir: 2 gms/day and taper – Valtrex: 1.5 gms/day and taper
• Stromal w/ Epithelial – Same as above until epithelium intact or concomitant
addition of corticosteroid • Stromal w/o Epithelial
– Oral as above – Corticosteroid q 1-3 hours initially (slow, slow taper)
Disciform HSV-K Antiviral prophylaxis1 Acyclovir 400 mg PO BID or Valacyclovir 500 mg PO QD
• HSV epithelial disease – Initial episode – no prophylaxis therapy – 1 or more recurrent episodes = oral therapy x 1 yr
• HSV stromal keratitis – Initial episode (uncomplicated) = oral therapy x 1 yr – Initial episode (complicated) = oral therapy x 2 yrs – Chronic disease = oral therapy 2 yrs to indefinite
1 1Welder JD, Kitzmann AS, Wagonger MD. Herpes Simplex Keratitis. Accessed online from http://
webeye.ophth.uiowa.edu.
7
Case Presentation HSV-K
• 28 yo Male c/o of irritation in RE while working on his mechanics job
• + hx of oral fever blisters • SLEx
– Unilateral conjunctival injection – Central dendritic epithelial defect
• + RB and + FL staining – ? Reduced corneal sensation
Case Presentation HSV-K: Day 1
Case Presentation HSV-K
• Diagnosed initial episode of epithelial HSV-K • Initiated therapy of Zirgan 5 X day and Valtrex
500 mg PO TID (#60) • RTC 2 days
HSV-K: Day 3
Case Presentation HSV-K
• Patient is symptomatically improved and compliant with meds
• Continue Valtrex 500 mg PO TID and reduce Zirgan to 3 X day
• RTC 2 days
HSK: Day 5
8
Case Presentation HSV-K
• Patient is symptomatically improved and compliant with meds
• Continue Valtrex 500 mg PO TID and continue Zirgan TID
• RTC 2 days
HSK: Day 7
• Discontinue Zirgan. Finish Rx of Valtrex. Follow up with primary care optometrist 2 weeks.
Case Presentation
• 44 y/o Female c/o blurred vision and red eye for 3 weeks
• Treated with Tobradex by doctor for two weeks with no improvement
• + hx of oral fever blisters • VA 2/400 • SLEx
– Large geographic area of epithelial loss – Decreased corneal sensation
Case Presentation
• 36 yo WM with hx of recurrent HSK • Most recent episode treated with Viroptic
over 2 week period on tapering scheduled • HSV-K recurred and Viroptic was restarted • Referred after 4 weeks of therapy
9
Management Metaherpetic HSK
• Discontinued Viroptic • Placed on Valtrex 500 mg TID and quickly
tapered to 500 mg QD maintenance • Minimal debridement of necrotic epithelium • Lubricants • Can use TSCL
Case Presentation
• 21 y/o male with hx of recurrent HSK reports decreased vision and redness for 1 week
• VA 20/80 • SLEx
– Active stromal HSV-K at edge of corneal scar – + FL – Decreased corneal sensation
Recurrent HSK
In Summary
• Always think HSV infection in unilateral red eye
• Follow standard of care in treating HSK THANK YOU